SCHEMBL28169333

SCHEMBL28169333

CCOC(=O)C(=Cc1ccc(Cl)cc1C(F)(F)F)N=[N+]=[N-]

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ PTPN1 P18031 1/20 0.36
▸ MAPT P10636 5/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ANO1 Q5XXA6 1/20 0.35
▸ GPR35 Q9HC97 1/20 0.35
▸ POLQ O75417 1/20 0.35
▸ HTT P42858 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 3/20 0.34
▸ MRGPRX4 Q96LA9 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ CCR2 P41597 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28169364 0.89 NPSR1 (0.41) ALDH1A1MAPTHPGDGPR35POLQ
SCHEMBL28463731 0.83 GAA (0.38) ALDH1A1PTPN1MAPTHPGDGPR35
SCHEMBL22080767 0.81 GAA (0.38) ALDH1A1PTPN1MAPTHPGDGPR35
SCHEMBL22042074 0.81 GAA (0.38) ALDH1A1PTPN1MAPTHPGDGPR35
SCHEMBL22042075 0.81 GAA (0.38) ALDH1A1PTPN1MAPTHPGDGPR35
SCHEMBL22647486 0.80 MAPT (0.39) ALDH1A1PTPN1MAPTHPGDLMNA
SCHEMBL22620690 0.80 MAPT (0.39) ALDH1A1PTPN1MAPTHPGDLMNA
SCHEMBL31416399 0.80 MAPT (0.36) ALDH1A1PTPN1MAPTHPGDGPR35
SCHEMBL18307352 0.79 NPSR1 (0.40) ALDH1A1MAPTHPGDGPR35LMNA
SCHEMBL30262303 0.79 NPSR1 (0.40) ALDH1A1MAPTHPGDGPR35LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107098846-B N-acyl sulfonamide FBPase inhibitor, preparation method thereof, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2020-10-09 — — CN disclosed
CN-107098846-A N- acyl sulfonamides class FBPase inhibitor, its preparation method, pharmaceutical composition and purposes 中国医学科学院药物研究所 2017-08-29 — — CN disclosed
Send feedback